Fante already fronts the company's commercial operations in North America. He will now also take on Central and South American responsibilities.
"Rich is a strong leader who will enable our company to successfully navigate the challenges facing our industry while delivering innovation and value to our customers, patients and shareholders," said Tony Zook, executive VP, global commercial operations.
New appointments at biopharma and equipment companies also feature in this week's column.
Plus other people on the move in the pharma industry in this week's column.
People are on the move at Baxter, Merck & Co., Johnson & Johnson, and elsewhere in this...
Twin changes at AstraZeneca's MedImmune kick off this week's gallery, as well as jobs news from Europe
UCB has more than drugs in its 2015 pipeline, while BUPA and biotechs hire new recruits.